Clarifying delirium management: Practical, evidenced-based, expert recommendations for clinical practice

Journal of Palliative Medicine

Volumn 16, Issue 4, 2013, Pages 423-435

  Irwin, Scott A ^a   Pirrello, Rosene D ^a   Hirst, Jeremy M ^a   Buckholz, Gary T ^a   Ferris, Frank D ^a  

^a San Diego Hospice and the Institute for Palliative Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; CHLORPROMAZINE; HALOPERIDOL; LORAZEPAM; MIDAZOLAM; NEUROLEPTIC AGENT; OPIATE; PHENOBARBITAL; PROPOFOL;

AGITATION; ARTICLE; BEHAVIOR DISORDER; CAREGIVER; CLINICAL FEATURE; CONTINUOUS INFUSION; DELIRIUM; DISEASE ACTIVITY; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ELIMINATION; DRUG INDICATION; DRUG RESPONSE; EVIDENCE BASED PRACTICE; FAMILY; HEALTH EDUCATION; HUMAN; LOADING DRUG DOSE; MUSCLE RELAXATION; PALLIATIVE THERAPY; PATIENT SAFETY; RECOMMENDED DRUG DOSE; RISK ASSESSMENT; SCREENING TEST; SEDATION; SOCIAL SUPPORT;

ANTIPSYCHOTIC AGENTS; DELIRIUM; EVIDENCE-BASED MEDICINE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; TERMINALLY ILL; TREATMENT OUTCOME;

EID: 84875853931     PISSN: 10966218     EISSN: 15577740     Source Type: Journal    
DOI: 10.1089/jpm.2012.0319     Document Type: Article

References (138)

1. Irwin SA, Buckholz GT, Pirrello RD, Hirst JM, Ferris FD: Recognizing and managing delirium. In: Berger A, Shuster JL, Von Roenn JH (eds): Principles and Practice of Palliative Care and Supportive Oncology. Philadelphia, PA: Lippincott Williams & Wilkins, 2013, pp. 529-542.
2. Agar M, Lawlor P: Delirium in cancer patients: A focus on treatment-induced psychopathology. Curr Opin Oncol 2008; 20:360-366.
3. Ganzini L: Care of patients with delirium at the end of life. Ann Long-Term Care 2007;15.
4. Breitbart W, Alici Y: Agitation and delirium at the end of life: ";We couldn't manage him."; JAMA 2008;300:2898-2910.
5. Breitbart W, Alici Y: Evidence-based treatment of delirium in patients with cancer. J Clin Oncol 2012;30:1206-1214.
6. Kang JH, Shin SH, Bruera E: Comprehensive approaches to managing delirium in patients with advanced cancer. Cancer Treat Rev 2012;38:105-112.
7. Jackson KC, Lipman AG: Drug therapy for delirium in terminally ill patients. Cochrane Database Syst Rev 2004: CD004770.
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association, 2000.
9. American Psychiatric Association: Practice guideline for the treatment of patients with delirium. Am J Psychiatry 1999;156:1-20.
10. Cook IA: Guidleine watch: Practice guideline for the treatment of patients with delirium. wwwpsychorg/ psych-pract/treatg/pg/prac-guidecfm. 2004. (Last accessed December 1, 2012.)
11. Boettger S, Breitbart W: Phenomenology of the subtypes of delirium: Phenomenological differences between hyperactive and hypoactive delirium. Palliat Support Care 2011;9: 129-135.
12. Stagno D, Gibson C, Breitbart W: The delirium subtypes: A review of prevalence, phenomenology, pathophysiology, and treatment response. Palliat Support Care 2004;2: 171-179.
13. O'Keeffe ST: Clinical subtypes of delirium in the elderly. Dement Geriatr Cogn Disord 1999;10:380-385.
14. Lipowski ZJ: Delirium in the elderly patient. N Engl J Med 1989;320:578-582.
15. Meagher D, Moran M, Raju B, Leonard M, Donnelly S, Saunders J, Trzepacz P: A new data-based motor subtype schema for delirium. J Neuropsychiatry Clin Neurosci 2008;20:185-193.
16. Fang CK, Chen HW, Liu SI, Lin CJ, Tsai LY, Lai YL: Prevalence, detection and treatment of delirium in terminal cancer inpatients: A prospective survey. Jpn J Clin Oncol 2008;38:56-63.
17. Spiller JA, Keen JC: Hypoactive delirium: Assessing the extent of the problem for inpatient specialist palliative care. Palliat Med 2006;20:17-23.
18. Ross CA, Peyser CE, Shapiro I, Folstein MF: Delirium: Phenomenologic and etiologic subtypes. Int Psychogeriatr 1991;3:135-147.
19. Meagher DJ, Moran M, Raju B, Gibbons D, Donnelly S, Saunders J, Trzepacz PT: Motor symptoms in 100 patients with delirium versus control subjects: Comparison of subtyping methods. Psychosomatics 2008;49:300-308.
20. Peterson JF, Pun BT, Dittus RS, Thomason JW, Jackson JC, Shintani AK, Ely EW: Delirium and its motoric subtypes: A study of 614 critically ill patients. J Am Geriatr Soc 2006;54:479-484.
21. Pompei P, Foreman M, Rudberg MA, Inouye SK, Braund V, Cassel CK: Delirium in hospitalized older persons: Outcomes and predictors. J Am Geriatr Soc 1994;42:809-815.
22. Inouye SK: Delirium in hospitalized older patients. Clin Geriatr Med 1998;14:745-764.
23. McNicoll L, Pisani MA, Zhang Y, Ely EW, Siegel MD, Inouye SK: Delirium in the intensive care unit: Occurrence and clinical course in older patients. J Am Geriatr Soc 2003;51:591-598.
24. Ely EW, Margolin R, Francis J, May L, Truman B, Dittus R, Speroff T, Gautam S, Bernard GR, Inouye SK: Evaluation of delirium in critically ill patients: Validation of the Confusion Assessment Method for the Intensive Care Unit (CAMICU). Crit Care Med 2001;29:1370-1379.
25. Hart RP, Levenson JL, Sessler CN, Best AM, Schwartz SM, Rutherford LE: Validation of a cognitive test for delirium in medical ICU patients. Psychosomatics 1996;37: 533-546.
26. Massie MJ, Holland J, Glass E: Delirium in terminally ill cancer patients. Am J Psychiatry 1983;140:1048-1050.
27. Breitbart W, Strout D: Delirium in the terminally ill. Clin Geriatr Med 2000;16:357-372.
28. Bruera E, Miller L, McCallion J, Macmillan K, Krefting L, Hanson J: Cognitive failure in patients with terminal cancer: A prospective study. J Pain Symptom Manage 1992;7:192-195.
29. Lawlor PG, Gagnon B, Mancini IL, Pereira JL, Hanson J, Suarez-Almazor ME, Bruera ED: Occurrence, causes, and outcome of delirium in patients with advanced cancer: A prospective study. Arch Intern Med 2000;160:786-794.
30. Gagnon P, Allard P, Masse B, DeSerres M: Delirium in terminal cancer: A prospective study using daily screening, early diagnosis, and continuous monitoring. J Pain Symptom Manage 2000;19:412-426.
31. Thomas RI, Cameron DJ, Fahs MC: A prospective study of delirium and prolonged hospital stay. Exploratory study. Arch Gen Psychiatry 1988;45:937-940.
32. Cole MG, Primeau FJ: Prognosis of delirium in elderly hospital patients. CMAJ 1993;149:41-46.
33. Inouye SK, Rushing JT, Foreman MD, Palmer RM, Pompei P: Does delirium contribute to poor hospital outcomes? A three-site epidemiologic study. J Gen Intern Med 1998; 13:234-242.
34. Trzepacz PT, Teague GB, Lipowski ZJ: Delirium and other organic mental disorders in a general hospital. Gen Hosp Psychiatry 1985;7:101-106.
35. Inouye SK: The dilemma of delirium: Clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients. Am J Med 1994;97:278-288.
36. Maltoni M, Amadori D: Prognosis in advanced cancer. Hematol Oncol Clin North Am 2002;16:715-729.
37. Casarett DJ, Inouye SK: Diagnosis and management of delirium near the end of life. Ann Intern Med 2001;135: 32-40.
38. Cole MG, Ciampi A, Belzile E, Zhong L: Persistent delirium in older hospital patients: A systematic review of frequency and prognosis. Age Ageing 2009;38:19-26.
39. Kiely DK, Marcantonio ER, Inouye SK, Shaffer ML, Bergmann MA, Yang FM, Fearing MA, Jones RN: Persistent delirium predicts greater mortality. J Am Geriatr Soc 2009;57:55-61.
40. Fainsinger R, Bruera E: Treatment of delirium in a terminally ill patient. J Pain Symptom Manage 1992;7:54-56.
41. Morita T, Tsunoda J, Inoue S, Chihara S: Survival prediction of terminally ill cancer patients by clinical symptoms: Development of a simple indicator. Jpn J Clin Oncol 1999; 29:156-159.
42. Inouye SK: Delirium in hospitalized older patients: Recognition and risk factors. J Geriatr Psychiatry Neurol 1998;11:118-125.
43. Inouye SK: Acute hospital care. Del Hosp Old Pats 1998;14:745-764.
44. Bruera E, Fainsinger RL, Miller MJ, Kuehn N: The assessment of pain intensity in patients with cognitive failure: A preliminary report. J Pain Symptom Manage 1992;7:267-270.
45. Fainsinger R, Miller MJ, Bruera E, Hanson J, Maceachern T: Symptom control during the last week of life on a palliative care unit. J Palliat Care 1991;7:5-11.
46. Coyle N, Breitbart W, Weaver S, Portenoy R: Delirium as a contributing factor to ";crescendo"; pain: Three case reports. J Pain Symptom Manage 1994;9:44-47.
47. Namba M, Morita T, Imura C, Kiyohara E, Ishikawa S, Hirai K: Terminal delirium: Families' experience. Palliat Med 2007;21:587-594.
48. Morita T, Akechi T, Ikenaga M, Inoue S, Kohara H, Matsubara T, Matsuo N, Namba M, Shinjo T, Tani K, Uchitomi Y: Terminal delirium: Recommendations from bereaved families' experiences. J Pain Symptom Manage 2007;34:579-589.
49. Bruera E, Bush SH, Willey J, Paraskevopoulos T, Li Z, Palmer JL, Cohen MZ, Sivesind D, Elsayem A: Impact of delirium and recall on the level of distress in patients with advanced cancer and their family caregivers. Cancer 2009;115:2004-2012.
50. Cohen MZ, Pace EA, Kaur G, Bruera E: Delirium in advanced cancer leading to distress in patients and family caregivers. J Palliat Care 2009;25:164-171.
51. Breitbart W, Gibson C, Tremblay A: The delirium experience: Delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses. Psychosomatics 2002;43:183-194.
52. Breitbart W, Marotta R, Platt MM, Weisman H, Derevenco M, Grau C, Corbera K, Raymond S, Lund S, Jacobson P: A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 1996;153:231-237.
53. Gaudreau JD, Gagnon P, Harel F, Roy MA, Tremblay A: Psychoactive medications and risk of delirium in hospitalized cancer patients. J Clin Oncol 2005;23:6712-6718.
54. Gaudreau JD, Gagnon P, Roy MA, Harel F, Tremblay A: Opioid medications and longitudinal risk of delirium in hospitalized cancer patients. Cancer 2007;109:2365-2373.
55. Bruera E, Macmillan K, Hanson J, MacDonald RN: The cognitive effects of the administration of narcotic analgesics in patients with cancer pain. Pain 1989;39:13-16.
56. Stiefel FC, Breitbart WS, Holland JC: Corticosteroids in cancer: Neuropsychiatric complications. Cancer Invest 1989;7:479-491.
57. Han L, McCusker J, Cole M, Abrahamowicz M, Primeau F, Elie M: Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med 2001;161:1099-1105.
58. Ancelin ML, Artero S, Portet F, Dupuy AM, Touchon J, Ritchie K: Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: Longitudinal cohort study. British Med J 2006;332:455-459.
59. Morita T, Tei Y, Tsunoda J, Inoue S, Chihara S: Underlying pathologies and their associations with clinical features in terminal delirium of cancer patients. J Pain Symptom Manage 2001;22:997-1006.
60. Levenson JL: Textbook of Psychosomatic Medicine. Washington, DC: American Psychiatric Publishing, 2005.
61. Leonard M, Raju B, Conroy M, Donnelly S, Trzepacz PT, Saunders J, Meagher D: Reversibility of delirium in terminally ill patients and predictors of mortality. Palliat Med 2008;22:848-854.
62. Breibart WS, Gibson C, Chochinov H: Palliative care. In: Levenson JL (ed): Textbook of Psychosomatic Medicine. Washington, DC: American Psychiatric Publishing, 2005, pp. 979-1007.
63. Lawlor PG, Bruera ED: Delirium in patients with advanced cancer. Hematol Oncol Clin North Am 2002;16: 701-714.
64. Schuurmans MJ, Deschamps PI, Markham SW, Shortridge- Baggett LM, Duursma SA: The measurement of delirium: Review of scales. Res Theory Nurs Pract 2003;17:207-224.
65. Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI: Clarifying confusion: The confusion assessment method. A new method for detection of delirium. Ann Intern Med 1990;113:941-948.
66. Inouye SK: The Confusion Assessment Method (CAM): Training Manual and Coding Guide. Yale University School of Medicine, New Haven, CT, 2003.
67. Ferris FD, Danilychev M, Siegel A: Last hours of living. In: Emanuel LL, Librach SL (eds): Palliative Care: Core Skills and Clinical Competencies. Philidelphia, PA: Saunders Elsevier, 2007, pp. 267-293.
68. Ferris FD: Last hours of living. Clin Geriatr Med 2004;20:641-667.
69. Rao S, Ferris FD, Irwin SA: Ease of screening for depression and delirium in patients enrolled in inpatient hospice care. J Palliat Med 2011;14:275-279.
70. Emanuel EJ, Ferris FD, von Gunten CF, von Roenn J: Education in Palliative and End-of-life Care for Oncology. Chicago: The EPEC Project-, 2005.
71. von Gunten CF, Sloan PA, Portenoy RK, Schonwetter RS: Physician board certification in hospice and palliative medicine. J Palliat Med 2000;3:441-447.
72. Emanuel LL, Librach SL: Palliative Care: Core Skills and Clinical Competencies. Philadelphia, PA: Saunders/Elsevier, 2007.
73. Ferris FD, Balfour HM, Bowen K, Farley J, Hardwick M, Lamontagne C, Lundy M, Syme A, West PJ: A model to guide patient and family care: Based on nationally accepted principles and norms of practice. J Pain Symptom Manage 2002;24:106-123.
74. Cole MG, Primeau FJ, Bailey RF, Bonnycastle MJ, Masciarelli F, Engelsmann F, Pepin MJ, Ducic D: Systematic intervention for elderly inpatients with delirium: A randomized trial. Cmaj 1994;151:965-970.
75. Cole MG, McCusker J, Bellavance F, Primeau FJ, Bailey RF, Bonnycastle MJ, Laplante J: Systematic detection and multidisciplinary care of delirium in older medical inpatients: A randomized trial. CMAJ 2002;167:753-759.
76. Pitkala KH, Laurila JV, Strandberg TE, Tilvis RS: Multicomponent geriatric intervention for elderly inpatients with delirium: A randomized, controlled trial. J Gerontol A Biol Sci Med Sci 2006;61:176-181.
77. Pitkala KH, Laurila JV, Strandberg TE, Kautiainen H, Sintonen H, Tilvis RS: Multicomponent geriatric intervention for elderly inpatients with delirium: Effects on costs and health-related quality of life. J Gerontol A Biol Sci Med Sci 2008;63:56-61.
78. Inouye SK, Bogardus ST, Jr., Charpentier PA, Leo-Summers L, Acampora D, Holford TR, Cooney LM, Jr.: A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999;340:669-676.
79. Bruera E, Belzile M, Watanabe S, Fainsinger RL: Volume of hydration in terminal cancer patients. Support Care Cancer 1996;4:147-150.
80. Dalal S, Bruera E: Dehydration in cancer patients: To treat or not to treat. J Support Oncol 2004;2:467-483.
81. Steiner N, Bruera E: Methods of hydration in palliative care patients. J Palliat Care 1998;14:6-13.
82. Inouye SK, Zhang Y, Jones RN, Kiely DK, Yang F, Marcantonio ER: Risk factors for delirium at discharge: Development and validation of a predictive model. Arch Intern Med 2007;167:1406-1413.
83. Gagnon P, Charbonneau C, Allard P, Soulard C, Dumont S, Fillion L: Delirium in advanced cancer: A psychoeducational intervention for family caregivers. J Palliat Care 2002;18:253-261.
84. Inouye SK, Bogardus ST, Jr., Williams CS, Leo-Summers L, Agostini JV: The role of adherence on the effectiveness of nonpharmacologic interventions: Evidence from the delirium prevention trial. Arch Intern Med 2003;163: 958-964.
85. Agar M, Currow D, Plummer J, Chye R, Draper B: Differing management of people with advanced cancer and delirium by four sub-specialties. Palliat Med 2008;22:633-640.
86. Schatzberg AF, Cole JO, DeBattista C: Manual of Clinical Psychopharmacology. Washington, DC: American Psychiatric Publishing 2007.
87. Clinical Pharmacology Online. wwwclinicalpharmacologyipcom/ defaultaspx. 2008. (Last accessed December 1, 2012.)
88. Allen MH, Currier GW, Hughes DH, Reyes-Harde M, Docherty JP: The Expert Consensus Guideline Series. Treatment of behavioral emergencies. Postgrad Med 2001:1-90.
89. Wise MG, Rundell JR: Clinical manual of psychosomatic medicine: A guide to consultation-liaison psychiatry. Arlington, VA: American Psychiatric Publishing 2005.
90. Bottomley DM, Hanks GW: Subcutaneous midazolam infusion in palliative care. J Pain Symptom Manage 1990;5:259-261.
91. Rundell JR, Wise MG, Press AP: Essentials of consultationliaison psychiatry : Based on the American Psychiatric Press textbook of consultation-liaison psychiatry. Washington, DC: American Psychiatric Press, 1999.
92. Marcantonio ER: In the clinic: Delirium. Ann Intern Med 2011;154:6-15.
93. Stahl SM: Stahl's essential psychopharmacology: Neuroscientific basis and practical applications. New York: Cambridge University Press, 2008.
94. Boettger S, Breitbart W: An open trial of aripiprazole for the treatment of delirium in hospitalized cancer patients. Palliat Support Care 2011;9:351-357.
95. Skrobik YK, Bergeron N, Dumont M, Gottfried SB: Olanzapine vs haloperidol: Treating delirium in a critical care setting. Intensive Care Med 2004;30:444-449.
96. Sipahimalani A, Masand PS: Olanzapine in the treatment of delirium. Psychosomatics 1998;39:422-430.
97. Han CS, Kim YK: A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 2004;45:297-301.
98. Richelson E: Preclinical pharmacology of neuroleptics: Focus on new generation compounds. J Clin Psychiatry 1996;57(S11):4-11.
99. Lonergan E, Britton Annette M, Luxenberg J: Antipsychotics for Delirium. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, 2007.
100. Wang PS, Schneeweiss S, Avorn J, Fischer MA, Mogun H, Solomon DH, Brookhart MA: Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 2005;353:2335-2341.
101. Ballard C, Hanney ML, Theodoulou M, Douglas S, McShane R, Kossakowski K, Gill R, Juszczak E, Yu L-M, Jacoby R: The dementia antipsychotic withdrawal trial (DART-AD): Long-term follow-up of a randomised placebo- controlled trial. Lancet Neurol 2009;8:151-157.
102. Ray WA, Chung CP, Murray KT, Hall K, Stein CM: Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 2009;360:225-235.
103. Gill SS, Bronskill SE, Normand S-LT, Anderson GM, Sykora K, Lam K, Bell CM, Lee PE, Fischer HD, Herrmann N, Gurwitz JH, Rochon PA: Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med 2007;146:775-786.
104. Schneeweiss S, Setoguchi S, Brookhart A, Dormuth C, Wang PS: Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients. CMAJ 2007;176:627-632.
105. Schneider LS, Dagerman KS, Insel P: Risk of death with atypical antipsychotic drug treatment for dementia: Metaanalysis of randomized placebo-controlled trials. JAMA 2005;294:1934-1943.
106. Jeste DV, Blazer D, Casey D, Meeks T, Salzman C, Schneider L, Tariot P, Yaffe K: ACNP White Paper: Update on use of antipsychotic drugs in elderly persons with dementia. Open Neuropsychopharmacol J 2008;33:957-970.
107. Schneider LS, Tariot PN, Dagerman KS, Davis SM, Hsiao JK, Ismail MS, Lebowitz BD, Lyketsos CG, Ryan JM, Stroup TS, Sultzer DL, Weintraub D, Lieberman JA: Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med 2006;355:1525-1538.
108. Elie D, Poirier M, Chianetta J, Durand M, Gregoire C, Grignon S: Cognitive effects of antipsychotic dosage and polypharmacy: A study with the BACS in patients with schizophrenia and schizoaffective disorder. J Psychopharmacol 2010;24:1037-1044.
109. Breitbart W, Cohen K: Delirium in the terminally ill. In: Chochinov HM, Breitbart W (eds): Handbook of Psychiatry in Palliative Medicine. New York: Oxford University Press, 2000.
110. Rousseau P: Palliative sedation in the management of refractory symptoms. J Support Oncol 2004;2:181-186.
111. Rousseau P: Palliative sedation in the control of refractory symptoms. J Palliat Med 2005;8:10-12.
112. Morita T, Tei Y, Inoue S: Agitated terminal delirium and association with partial opioid substitution and hydration. J Palliat Med 2003;6:557-563.
113. Stiefel F, Fainsinger R, Bruera E: Acute confusional states in patients with advanced cancer. J Pain Symptom Manage 1992;7:94-98.
114. Ventafridda V, Ripamonti C, De Conno F, Tamburini M, Cassileth BR: Symptom prevalence and control during cancer patients' last days of life. J Palliat Care 1990;6:7-11.
115. Fainsinger RL, Waller A, Bercovici M, Bengtson K, Landman W, Hosking M, Nunez-Olarte JM, deMoissac D: A multicentre international study of sedation for uncontrolled symptoms in terminally ill patients. Palliat Med 2000;14:257-265.
116. Rietjens JA, van Zuylen L, van Veluw H, van der Wijk L, van der Heide A, van der Rijt CC: Palliative sedation in a specialized unit for acute palliative care in a cancer hospital: Comparing patients dying with and without palliative sedation. J Pain Symptom Manage 2008;36:228-234.
117. Connor SR, Pyenson B, Fitch K, Spence C, Iwasaki K: Comparing hospice and nonhospice patient survival among patients who die within a three-year window. J Pain Symptom Manage 2007;33:238-246.
118. Platt MM, Breitbart W, Smith M, Marotta R, Weisman H, Jacobsen PB: Efficacy of neuroleptics for hypoactive delirium. J Neuropsychiatry Clin Neurosci 1994;6:66-67.
119. Maltoni M, Scarpi E, Rosati M, Derni S, Fabbri L, Martini F, Amadori D, Nanni O: Palliative sedation in end-of-life care and survival: A systematic review. J Clin Oncol 2012;30: 1378-1383.
120. Sykes N, Thorns A: Sedative use in the last week of life and the implications for end-of-life decision making. Arch Intern Med 2003;163:341-344.
121. Vitetta L, Kenner D, Sali A: Sedation and analgesia-prescribing patterns in terminally ill patients at the end of life. Am J Hosp Palliat Care 2005;22:465-473.
122. Morita T, Chinone Y, Ikenaga M, Miyoshi M, Nakaho T, Nishitateno K, Sakonji M, Shima Y, Suenaga K, Takigawa C: Efficacy and Safety of Palliative Sedation Therapy: A multicenter, prospective, observational study conducted on specialized palliative care units in Japan. J Pain Symptom Manage 2005;30:320-328.
123. Good PD, Ravenscroft PJ, Cavenagh J: Effects of opioids and sedatives on survival in an Australian inpatient palliative care population. Intern Med J 2005;35:512-517.
124. Bercovitch M, Adunsky A: Patterns of high-dose morphine use in a home-care hospice service: Should we be afraid of it? Cancer 2004;101:1473-1477.
125. Bercovitch M, Waller A, Adunsky A: High dose morphine use in the hospice setting: A database survey of patient characteristics and effect on life expectancy. Cancer 1999;86: 871-877.
126. Portenoy RK, Sibirceva U, Smout R, Horn S, Connor S, Blum RH, Spence C, Fine PG: Opioid use and survival at the end of life: A survey of a hospice population. J Pain Symptom Manage 2006;32:532-540.
127. Lundstrom S, Zachrisson U, Furst CJ: When nothing helps: Propofol as sedative and antiemetic in palliative cancer care. J Pain Symptom Manage 2005;30:570-577.
128. Lundstrom S, Twycross R, Mihalyo M, Wilcock A: Propofol. J Pain Symptom Manage 2010;40:466-470.
129. Stirling LC, Kurowska A, Tookman A: The use of phenobarbitone in the management of agitation and seizures at the end of life. J Pain Symptom Manage 1999;17:363-368.
130. Meagher D: Motor subtypes of delirium: Past, present and future. Int Rev Psychiatry 2009;21:59-73.
131. Hanson E, Healey K, Wolf D, Kohler C: Assessment of pharmacotherapy for negative symptoms of schizophrenia. Curr Psychiatry Rep 2010;12:563-571.
132. Swerdlow NR: Are we studying and treating schizophrenia correctly? Schizophr Res 2011;130:1-10.
133. Buss MK, Vanderwerker LC, Inouye SK, Zhang B, Block SD, Prigerson HG: Associations between caregiver-perceived delirium in patients with cancer and generalized anxiety in their caregivers. J Palliat Med 2007;10:1083-1092.
134. Rosenbloom-Brunton DA, Henneman EA, Inouye SK: Feasibility of family participation in a delirium prevention program for hospitalized older adults. J Gerontol Nurs 2010;36:22-33.
135. Plonk WM, Jr., Arnold RM: Terminal care: The last weeks of life. J Palliat Med 2005;8:1042-1054.
136. Tang ST: Supporting cancer patients dying at home or at a hospital for Taiwanese family caregivers. Cancer Nurs 2009;32:151-157.
137. Ferris FD, Flannery JS, McNeal HB, Morissette MR, Cameron R, Bally GA, eds.: Advance planning. Module 4: Palliative care. In: A Comprehensive Guide for the Care of Persons with HIV Disease. Toronto, Ontario: Mount Sinai Hospital and Casey House Hospice Inc.; 1995:118-120.
138. Originally published in: Freemon FR. Delirium and organic psychosis. In: Organic Mental Disease. Jamaica, NY: SP Medical and Scientific Books; 1981:81-94.